Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study

Published:2008-05 Issue:5 Volume:23 Page:729-735
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Lee Hyun Woong,Lee Joung Il,Um Soon Ho,Ahn Sang Hoon,Chang Hye Young,Park Yong Kwang,Hong Sun Pyo,Moon Young Myoung,Han Kwang-Hyub

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1746.2008.05387.x/fullpdf

Reference32 articles.

1. Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B

2. Current Treatment of Chronic Hepatitis B: Benefits and Limitations

3. Clinical Trial Results of New Therapies for HBV: Implications for Treatment Guidelines

4. The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial

5. Thymalfasin for the treatment of chronic hepatitis B

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application;Molecules;2023-04-17

2. Development of a Highly Efficient Hybrid Peptide That Increases Immunomodulatory Activity Via the TLR4-Mediated Nuclear Factor-κB Signaling Pathway;International Journal of Molecular Sciences;2019-12-06

3. Design and Development of a Novel Peptide for Treating Intestinal Inflammation;Frontiers in Immunology;2019-08-06

4. Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label study;Expert Opinion on Biological Therapy;2018-05-31

5. Chronic hepatitis B: A wave of new therapies on the horizon;Antiviral Research;2015-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3